-
公开(公告)号:EP3386495A1
公开(公告)日:2018-10-17
申请号:EP16808622.1
申请日:2016-12-07
申请人: INSERM (Institut National de la Santé et de la Recherche Médicale) , Université d'Aix Marseille , Centre National de la Recherche Scientifique (CNRS) , Université Paris Descartes , Assistance Publique-Hôpitaux de Paris (APHP)
IPC分类号: A61K31/16 , A61K31/165 , A61K31/341 , A61K31/381 , A61K31/4453 , A61K31/5375 , A61P37/00
CPC分类号: G01N33/573 , A61K31/16 , A61K31/165 , A61K31/341 , A61K31/381 , A61K31/4453 , A61K31/5375 , G01N2333/98 , G01N2800/24
摘要: The present invention relates to methods and pharmaceutical compositions for the treatment of systemic sclerosis. In particular, the present invention relates to a method of treating systemic sclerosis in a subject in need thereof comprising administering to the subject a therapeutically effective amount of vanin-1 inhibitor.